These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7536971)

  • 1. Cellular basis of acquired immunologic tolerance following total bowel transplantation in rats. I. Relation between donor lymphocyte chimerism and host-cell-mediated immunity.
    Masaki Y; Kimura H; Oohara T
    Transplant Proc; 1995 Apr; 27(2):1585-8. PubMed ID: 7536971
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts.
    Masaki Y; Oohara T; Shinomiya T; Kimura H
    Transplant Proc; 1995 Apr; 27(2):1589-92. PubMed ID: 7536972
    [No Abstract]   [Full Text] [Related]  

  • 3. Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation.
    Llull R; Murase N; Demetris AJ; Ye Q; Manez R; Starzl TE
    Transplant Proc; 1995 Aug; 27(4):2363-4. PubMed ID: 7544504
    [No Abstract]   [Full Text] [Related]  

  • 4. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
    Siemionow MZ; Klimczak A; Unal S
    Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host reaction.
    Llull R; Murase N; Ye Q; Manez R; Demetris AJ; Fournier V; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):164-5. PubMed ID: 7878956
    [No Abstract]   [Full Text] [Related]  

  • 6. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance induced by direct inoculation of donor antigen into the thymus in low and high responder rodents.
    Alfrey EJ; Wang X; Lee L; Holm B; Kim J; Adams G; Dafoe DC
    Transplantation; 1995 Apr; 59(8):1171-6. PubMed ID: 7732564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cellular basis of transplantation tolerance.
    Elkins WL
    Transplant Proc; 1973 Mar; 5(1):685-9. PubMed ID: 4144461
    [No Abstract]   [Full Text] [Related]  

  • 9. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor bone marrow in laryngeal transplantation: results of a rat study.
    Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
    Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer.
    Muramatsu K; Valenzuela RG; Bishop AT
    J Orthop Res; 2003 Nov; 21(6):1056-62. PubMed ID: 14554219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular mechanisms of alloimmune non-responsiveness in tolerant mixed lymphocyte chimeras induced by vascularized bone marrow transplants.
    Llull R; Ramsamooj R; Black KS; Hewitt CW
    Transpl Int; 1994; 7 Suppl 1():S453-6. PubMed ID: 11271279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen mixed leukocyte chimerism and induction of tolerance in rat renal allograft recipients conditioned with donor-specific blood transfusions and cyclosporine.
    Llull R; Mañez R; Domenech N; Starzl TE; Black KS; Hewitt CW
    Transplant Proc; 1995 Aug; 27(4):2374-6. PubMed ID: 7652844
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed chimerism demonstrated in rats which have accepted heart allografts by intrathymic administration of bone marrow cells.
    Tahara H; Matsuura T; Imanishi M; Hara Y; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1969. PubMed ID: 8066637
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tolerance to small bowel allotransplants by mixed allogeneic chimerism.
    Orloff MS; Orloff SL; DeMara EM; Coppage ML; Leong N; Fallon MA
    Transplant Proc; 1994 Jun; 26(3):1585-6. PubMed ID: 8030048
    [No Abstract]   [Full Text] [Related]  

  • 19. Donor pretreatment with bone marrow cells for prevention of graft-versus-host reaction after small bowel transplantation.
    Kimura Y; Tanaka S; Tanaka N
    Transplant Proc; 1998 Nov; 30(7):3885-7. PubMed ID: 9838700
    [No Abstract]   [Full Text] [Related]  

  • 20. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.